United States · FDA National Drug Code directory
LETROZOLE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-1526_f187c05f-b55e-47f9-9c42-ee3640d28bfd
- Product NDC
- 71335-1526
- Form
- TABLET
- Composition / generic term
- LETROZOLE
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110604
- Source listing expiry
- 20271231
Source-listed ingredients
- LETROZOLE — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (71335-1526-1) · 71335-1526-1
- 10 TABLET in 1 BOTTLE (71335-1526-2) · 71335-1526-2
- 90 TABLET in 1 BOTTLE (71335-1526-3) · 71335-1526-3
- 40 TABLET in 1 BOTTLE (71335-1526-4) · 71335-1526-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →